{
    "Trade/Device Name(s)": [
        "Elecsys Anti-Tg"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K222610",
    "Predicate Device Reference 510(k) Number(s)": [
        "K053426"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JZO"
    ],
    "Summary Letter Date": "September 15, 2023",
    "Summary Letter Received Date": "May 19, 2023",
    "Submission Date": "August 25, 2022",
    "Regulation Number(s)": [
        "21 CFR 866.5870"
    ],
    "Regulation Name(s)": [
        "Thyroid Autoantibody Immunological Test System"
    ],
    "Analyte Class(es)": [
        "autoimmune",
        "immunology"
    ],
    "Analyte(s)": [
        "Antibodies to thyroglobulin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Standard serum tube",
        "Serum tube with separating gel",
        "K2-EDTA tube",
        "K3-EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "cobas e 411 immunoassay analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemiluminescence immunoassay (ECLIA)",
        "Competitive immunoassay"
    ],
    "Methodologies": [
        "Quantitative immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Roche Elecsys Anti-Tg immunoassay for quantitative detection of anti-thyroglobulin antibodies in human serum and plasma using ECLIA on cobas e 411 analyzer.",
    "Indications for Use Summary": "Immunoassay for the in vitro quantitative determination of antibodies to thyroglobulin in human serum and plasma as an aid in the detection of autoimmune thyroid diseases, for use with cobas e 411 immunoassay analyzer.",
    "fda_folder": "Immunology"
}